Therapeutics News and Research

RSS
New links in the cystic fibrosis chain uncover potential therapeutics

New links in the cystic fibrosis chain uncover potential therapeutics

New therapy for chronic spasticity and rigidity

New therapy for chronic spasticity and rigidity

New knowledge about basic cancer biology

New knowledge about basic cancer biology

Findings could lead to new therapy for spinal cord injury

Findings could lead to new therapy for spinal cord injury

Landmark stent trial to be presented at TCT 2007

Landmark stent trial to be presented at TCT 2007

Agency for Healthcare Research and Quality expands research on therapeutics program

Agency for Healthcare Research and Quality expands research on therapeutics program

The importance of the endocannabinoid-system

The importance of the endocannabinoid-system

First high-res 3D structures of first mammalian GRP94 protein solved

First high-res 3D structures of first mammalian GRP94 protein solved

Accentia announces investigational new drug application for Revimmune for refractory MS

Accentia announces investigational new drug application for Revimmune for refractory MS

Study links chemical to inhibited milk synthesis, secretion in humans

Study links chemical to inhibited milk synthesis, secretion in humans

New insight on jumping genes

New insight on jumping genes

Sir Martin Evans wins Nobel prize for stem cell research

Sir Martin Evans wins Nobel prize for stem cell research

Taking antidepressants with painkillers dangerous

Taking antidepressants with painkillers dangerous

SSRIs may double risk of gastrointestinal bleeding

SSRIs may double risk of gastrointestinal bleeding

Wyeth Pharmaceuticals to acquire Haptogen

Wyeth Pharmaceuticals to acquire Haptogen

Fraunhofer pharmaceutical agent speeds drug development

Fraunhofer pharmaceutical agent speeds drug development

Gates Foundation leads the charge against tuberculosis with Northeastern University

Gates Foundation leads the charge against tuberculosis with Northeastern University

Isis Pharmaceuticals awarded $1.5 million NIH grant to improve RNAi-based therapeutics

Isis Pharmaceuticals awarded $1.5 million NIH grant to improve RNAi-based therapeutics

Bath emollients for allergic eczema of 'questionable' value

Bath emollients for allergic eczema of 'questionable' value

Daisy compound used to attack cancer stem cells

Daisy compound used to attack cancer stem cells